Blood Cell Technologies, LLC is an early-stage research and development biopharmaceutical company and resident of JLABS@NYC. We are focused on the identification, validation and commercialization of novel drug targets and compounds that may be used to diagnose or treat disease. This is accomplished by identifying novel cellular targets, targeted drug development and novel biomarker development. Areas of interest include hematology, metabolism, antioxidants and cancer.